Work

Synchronous bilateral breast cancer with heterogeneous hormone receptor status: a case report

Year: 2024

Type: article

Abstract: The expression of estrogen, progesterone, and HER2 receptors in breast cancer cells helps guide treatment and predict outcomes. When the status of these receptors is heterogeneous, it makes treatment planning more complex. We present the case of a 72-year-old woman with bilateral breast cancer with heterogenous receptor status and subsequent challenges in management.

Source: Journal of Surgical Case Reports

DOI: 10.1093/jscr/rjae786

Authors: Prajjwol Luitel, Badal Karki, Sujan Paudel, Asim Shrestha, Suraj Pariyar, Suzita Hirachan

Institutions: Tribhuvan University, Maharajgunj Medical Campus, Institute of Medicine, Tribhuvan University Teaching Hospital

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,050